Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00819832 · OUTCOME

Phase 1: Time to Maximal Circulating Tumor Cell Burden (CTCB)

Anderson Circulating Tumor Cell Burden (CTCB) Study · Source last updated 2023-03-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Pre-procedure baseline blood draws through post surgery 24 hours followed at 7 days (+/- 2 days)

What was measured

Increase in number of cancer cells in patient's blood after standard kyphoplasty or vertebroplasty treatment of broken back bones that may have been caused by cancer measured by CTCB evaluation from peripheral blood (10cc) collected at 8 varying time points for a total of 100 cc collected over the 7 day period of time (10, 30, and 60 minutes, and then at 2 hours, and between 6-8 hours, 10-18 hours, 20-28 hours, and 7 days after the surgery).

Analysis population: Study terminated by sponsor; No data analysis done on limited amount of data gathered.

Groups in this outcome

Phase 1 Group 1 Vertebroplasty

Vertebroplasty

Phase 1 Group 2 Kyphoplasty

Kyphoplasty

Phase 2 Group 1 Vertebroplasty

Vertebroplasty

Phase 2 Group 2 Vertebroplasty +Cavity SpineWand

Vertebroplasty with Cavity SpineWand

Phase 2 Group 3 Kyphoplasty

Kyphoplasty

Phase 2 Group 4 Kyphoplasty + Cavity SpineWand

Kyphoplasty with Cavity SpineWand

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Phase 1 Group 1 Vertebroplasty0
Phase 1 Group 2 Kyphoplasty0
Phase 2 Group 1 Vertebroplasty0
Phase 2 Group 2 Vertebroplasty +Cavity SpineWand0
Phase 2 Group 3 Kyphoplasty0
Phase 2 Group 4 Kyphoplasty + Cavity SpineWand0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    3. group Id
      OG002
      value
      0
    4. group Id
      OG003
      value
      0
    5. group Id
      OG004
      value
      0
    6. group Id
      OG005
      value
      0
    units
    Participants
description
Increase in number of cancer cells in patient's blood after standard kyphoplasty or vertebroplasty treatment of broken back bones that may have been caused by cancer measured by CTCB evaluation from peripheral blood (10cc) collected at 8 varying time points for a total of 100 cc collected over the 7 day period of time (10, 30, and 60 minutes, and then at 2 hours, and between 6-8 hours, 10-18 hours, 20-28 hours, and 7 days after the surgery).
groups
  1. description
    Vertebroplasty
    id
    OG000
    title
    Phase 1 Group 1 Vertebroplasty
  2. description
    Kyphoplasty
    id
    OG001
    title
    Phase 1 Group 2 Kyphoplasty
  3. description
    Vertebroplasty
    id
    OG002
    title
    Phase 2 Group 1 Vertebroplasty
  4. description
    Vertebroplasty with Cavity SpineWand
    id
    OG003
    title
    Phase 2 Group 2 Vertebroplasty +Cavity SpineWand
  5. description
    Kyphoplasty
    id
    OG004
    title
    Phase 2 Group 3 Kyphoplasty
  6. description
    Kyphoplasty with Cavity SpineWand
    id
    OG005
    title
    Phase 2 Group 4 Kyphoplasty + Cavity SpineWand
population Description
Study terminated by sponsor; No data analysis done on limited amount of data gathered.
reporting Status
POSTED
time Frame
Pre-procedure baseline blood draws through post surgery 24 hours followed at 7 days (+/- 2 days)
title
Phase 1: Time to Maximal Circulating Tumor Cell Burden (CTCB)
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice